| Matthew Seigerman, | |
|
1305 Post Rd, Fairfield, CT 06824-6016 | |
| (203) 292-2000 | |
| Not Available |
| Full Name | Matthew Seigerman |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 9 Years |
| Location | 1305 Post Rd, Fairfield, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164817623 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0011X | Internal Medicine - Interventional Cardiology | 70183 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Yale-new Haven Hospital | New haven, CT | Hospital |
| St. Vincent's Medical Center | Bridgeport, CT | Hospital |
| Griffin Hospital | Derby, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
| Bridgeport Hospital | 2062312598 | 93 |
News Archive
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
An international team of scientists, involving Professor Rodrigo Quian Quiroga, director of the Centre for Systems Neuroscience and Head of Bioengineering at the University of Leicester, has shown how individual neurons in the human brain react to ambiguous morphed faces.
Smokers appear to have an increased long-term risk and greater progression of the eye disease age-related macular degeneration, according to a report in the January issue of Archives of Ophthalmology.
A new report suggests that the number of cases of extensively drug-resistant tuberculosis (XDR-TB) in the U.S. has declined in the past fifteen years, but new cases continue to be reported, according to the study published in the November 12 issue of JAMA.
› Verified 4 days ago
| Entity Name | Bridgeport Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649260845 PECOS PAC ID: 2062312598 Enrollment ID: O20040120000425 |
News Archive
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
An international team of scientists, involving Professor Rodrigo Quian Quiroga, director of the Centre for Systems Neuroscience and Head of Bioengineering at the University of Leicester, has shown how individual neurons in the human brain react to ambiguous morphed faces.
Smokers appear to have an increased long-term risk and greater progression of the eye disease age-related macular degeneration, according to a report in the January issue of Archives of Ophthalmology.
A new report suggests that the number of cases of extensively drug-resistant tuberculosis (XDR-TB) in the U.S. has declined in the past fifteen years, but new cases continue to be reported, according to the study published in the November 12 issue of JAMA.
› Verified 4 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
An international team of scientists, involving Professor Rodrigo Quian Quiroga, director of the Centre for Systems Neuroscience and Head of Bioengineering at the University of Leicester, has shown how individual neurons in the human brain react to ambiguous morphed faces.
Smokers appear to have an increased long-term risk and greater progression of the eye disease age-related macular degeneration, according to a report in the January issue of Archives of Ophthalmology.
A new report suggests that the number of cases of extensively drug-resistant tuberculosis (XDR-TB) in the U.S. has declined in the past fifteen years, but new cases continue to be reported, according to the study published in the November 12 issue of JAMA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Seigerman, 1305 Post Rd, Fairfield, CT 06824-6016 Ph: (203) 292-2000 | Matthew Seigerman, 1305 Post Rd, Fairfield, CT 06824-6016 Ph: (203) 292-2000 |
News Archive
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
An international team of scientists, involving Professor Rodrigo Quian Quiroga, director of the Centre for Systems Neuroscience and Head of Bioengineering at the University of Leicester, has shown how individual neurons in the human brain react to ambiguous morphed faces.
Smokers appear to have an increased long-term risk and greater progression of the eye disease age-related macular degeneration, according to a report in the January issue of Archives of Ophthalmology.
A new report suggests that the number of cases of extensively drug-resistant tuberculosis (XDR-TB) in the U.S. has declined in the past fifteen years, but new cases continue to be reported, according to the study published in the November 12 issue of JAMA.
› Verified 4 days ago
Dr. Igal Staw, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Post Rd, Ste 202, Fairfield, CT 06824 Phone: 203-853-1919 Fax: 203-855-9002 | |
Dr. Fereshteh Ahmadian, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 111 Beach Rd, Ste 3, Fairfield, CT 06824 Phone: 203-255-2340 | |
Mr. Adrian Dafcik, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 134 Round Hill Road, Fairfield, CT 06824 Phone: 203-255-0695 Fax: 203-255-0629 | |
Ana Patricia Echeverri, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Beach Rd Ste 3, Fairfield, CT 06824 Phone: 203-255-2340 Fax: 203-255-0619 | |
Dr. Peter R Cimino, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Post Rd, Suite 202, Fairfield, CT 06824 Phone: 203-255-8827 Fax: 203-259-4610 | |
Dr. Kenneth C Fine, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Jefferson St, Fairfield, CT 06825 Phone: 203-365-6473 Fax: 203-396-1039 | |
Dr. Slava I Kulakov, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 134 Round Hill Rd, Fairfield, CT 06824 Phone: 203-255-0695 Fax: 203-255-0629 |